Loading
CB
Cellular Biomedicine Group, Inc. Stock: price and insider trades · United States
Cellular Biomedicine Group, Inc.: what insiders have been doing
Every trade that managers of Cellular Biomedicine Group, Inc. disclose to SEC (Form 4) is tracked on this page. Cellular Biomedicine Group, Inc. has had no insider filing for more than a year; the last one goes back to 21 January 2016.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
2 ops. · all time
Last declaration on 21 January 2016
Declarations4 total
1,516 sharesCommon StockSEC:0001354488-16-005954:0
1,516 sharesCommon StockSEC:0001354488-16-005954:1
1,296 sharesCommon StockSEC:0001354488-16-005954:2
1,296 sharesCommon StockSEC:0001354488-16-005954:3
4 of 4 declarations
About Cellular Biomedicine Group, Inc.
Cellular Biomedicine Group, Inc. is a company focused on developing cell therapies for the treatment of serious diseases. It is listed on NASDAQ under the symbol CBMG.
